Indian pharma industry to hit $57 billion by FY25

CareEdge Ratings expect higher export growth rates for emerging markets compared to growth rates of developed markets

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.